Galderma Laboratories has agreed to a $990K settlement to resolve the class action lawsuit that alleged certain Differin acne products contained benzene, a known carcinogen
Galderma Laboratories has agreed to a $990K settlement to resolve the class action lawsuit that alleged certain Differin acne products contained benzene, a known carcinogen